Familial Pancreatic Cancer
AbstractPancreatic cancer’s high mortality rate equates closely with its incidence, thereby showing the need for development of biomarkers of its increased risk and a better understanding of its genetics, so that high-risk patients can be better targeted for screening and early potential lifesaving diagnosis. Its phenotypic and genotypic heterogeneity is extensive and requires careful scrutiny of its pattern of cancer associations, such as malignant melanoma associated with pancreatic cancer, in the familial atypical multiple mole melanoma syndrome, due to the CDKN2A germline mutation. This review is designed to depict several of the hereditary pancreatic cancer syndromes with particular attention given to the clinical application of this knowledge into improved control of pancreatic cancer. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Lynch, H.T.; Lynch, J.F.; Lanspa, S.J. Familial Pancreatic Cancer. Cancers 2010, 2, 1861-1883.
Lynch HT, Lynch JF, Lanspa SJ. Familial Pancreatic Cancer. Cancers. 2010; 2(4):1861-1883.Chicago/Turabian Style
Lynch, Henry T.; Lynch, Jane F.; Lanspa, Stephen J. 2010. "Familial Pancreatic Cancer." Cancers 2, no. 4: 1861-1883.